MBCOF (Marvel Biosciences) Interest Expense: $-0.23 Mil (TTM As of Apr. 2026)


MBCOF Marvel Biosciences Corp MBCOF
34 GF Score
Price $0.11
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences Interest Expense?

Marvel Biosciences MBCOF 34 Interest Expense is $-0.23 Mil as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Marvel Biosciences's interest expense for the three months ended in Apr. 2026 was $ -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.23 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Marvel Biosciences's Operating Income for the three months ended in Apr. 2026 was $ 0.09 Mil. Marvel Biosciences's Interest Expense for the three months ended in Apr. 2026 was $ -0.03 Mil. Marvel Biosciences's Interest Coverage for the quarter that ended in Apr. 2026 was 2.97. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Marvel Biosciences  (OTCPK:MBCOF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Marvel Biosciences's Interest Expense for the three months ended in Apr. 2026 was $-0.03 Mil. Its Operating Income for the three months ended in Apr. 2026 was $0.09 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Apr. 2026 was $0.45 Mil.

Marvel Biosciences's Interest Coverage for the quarter that ended in Apr. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Apr. 2026 )/Interest Expense (Q: Apr. 2026 )
=-1*0.086/-0.029
=2.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Marvel Biosciences Interest Expense Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Interest Expense Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Interest Expense
Get a 7-Day Free Trial -0.00 -0.00 -0.03 -0.08 -0.20

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.12 -0.04 -0.04 -0.03
MBCOF
34GF Score
Marvel Biosciences Corp MBCOF
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.23 Mil mean?
Marvel Biosciences (MBCOF) has a Interest Expense of $-0.23 Mil as of Apr. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Marvel Biosciences and its competitors.
Is Marvel Biosciences' Interest Expense too high?
Marvel Biosciences' current Interest Expense is $-0.23 Mil. Overall, Marvel Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Interest Expense compare to VRTX and REGN?
Marvel Biosciences' Interest Expense of $-0.23 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Marvel Biosciences and its competitors. Marvel Biosciences's current Interest Expense is $-0.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Interest Expense of $-0.23 Mil. The current Interest Expense is $-0.23 Mil. Marvel Biosciences' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Interest Expense is $-0.23 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
34GF Score

Get the complete analysis for MBCOF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price